Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    TH3RESA
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy
Condition: Breast Cancer
Interventions: Drug: Trastuzumab emtansine;   Drug: Treatment of physician's choice

Study has passed its completion date and status has not been verified in more than two years.